20 July 2020 1 Min Read
Synairgen shares soar after finding drug cuts Covid-19 severity
The inhaled product is a formulation of a naturally occurring protein that Synairgen has previously said may be deficient in those with greater susceptibility to Covid-19
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In